Push for COVID-19 vaccine patent waiver isn't a panacea: but it could nudge companies to share
By Enrico Bonadio, Reader in Intellectual Property Law, City, University of London
Filippo Fontanelli, Senior Lecturer in International Economic Law, University of Edinburgh
Waiver talks might convince companies to focus on technology transfer and training, and let go of the plan to maximise patent-based revenues.
Read complete article
© The Conversation
- Wednesday, May 12, 2021